BENITEC has won a new US patent covering its core RNAi technology.
The company says the US Patent Office issued a notice of allowance over a new patent called Multiple Promoter Expression Cassettes for Simultaneous Delivery of RNAi Agents.
This invention provides multiple-promoter expression cassettes for simultaneous delivery of RNAi, preferably to mammalian cells in vivo.
Benitec also says one of the key patents it has an option to license from City of Hope was issued in Japan. The patent, Ribozymes Capable of Inhibiting the Expression of the CCR5 Receptor, was issued in late June.
There is alot more to come ..this is just the beginning
BLT Price at posting:
4.4¢ Sentiment: Buy Disclosure: Held
